U.S. National Institutes of Health
U.S. National Institutes of Health

IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2325123251The Effect of Acupuncture Protocol Involving in Weizhong (BL4) and Huantiao (GB30) Points in Treating Ankylosing SpondylitisEnrolling by invitationNo Results AvailableAnkylosing SpondylitisOther: Weizhong and Huantiao|Other: A-shi pointhttps://ClinicalTrials.gov/show/NCT02260310
2325223252A Study of Wrist Actigraphy in Overweight and Obese Adults With Sleep DisordersCompletedNo Results AvailableSleep DisordersDevice: Wrist Actigraphy(motion sensors)with light sensors-Jawbone Up 2https://ClinicalTrials.gov/show/NCT02260297
2325323253The Effect of Acupotome in Treating Ankylosing SpondylitisEnrolling by invitationNo Results AvailableAnkylosing SpondylitisOther: Acupotome(needle knife)|Other: Controlhttps://ClinicalTrials.gov/show/NCT02260284
2325423254Florida Neonatal Neurologic NetworkEnrolling by invitationNo Results AvailableHypoxic-Ischemic EncephalopathyOther: Database Entry/Biospecimen Collectionhttps://ClinicalTrials.gov/show/NCT02260271
2325523255Neuromuscular Blockade for Post-Cardiac Arrest CareRecruitingNo Results AvailableCardiac ArrestDrug: Rocuronium|Drug: Normal Salinehttps://ClinicalTrials.gov/show/NCT02260258
2325623256Stepping Up for Safety: Improving Teamwork at the Planned Parenthood Affiliates Through the TeamSTEPPS ModelEnrolling by invitationNo Results AvailableImproving Team Work at the Planned Parenthood AffiliatesBehavioral: Team training using the TeamSTEPPS modelhttps://ClinicalTrials.gov/show/NCT02260245
2325723257Worksite Exercise Intervention Effects on Cardiovascular Disease Risk Factors and Physical Activity Levels Among Healthy EmployeesCompletedNo Results AvailableExercise TherapyOther: exercise traininghttps://ClinicalTrials.gov/show/NCT02260232
2325823258Comparative Study, Safety and Efficacy, Ahmed Glaucoma Drainage Device, Model M4 Model S2 in Neovascular GlaucomaActive, not recruitingNo Results AvailableNeovascular GlaucomaProcedure: Surgical Implant of Ahmed Glaucoma Drainage Device, model M4 and S2https://ClinicalTrials.gov/show/NCT02260219
2325923259Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial EffusionRecruitingNo Results AvailablePericardial EffusionDrug: Colchicinehttps://ClinicalTrials.gov/show/NCT02260206
232602326016-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Subjects With End Stage Renal Disease (ESRD) Requiring Chronic HemodialysisActive, not recruitingNo Results AvailableAnemia|End Stage Renal DiseaseDrug: AKB-6548|Drug: AKB-6548|Drug: AKB-6548https://ClinicalTrials.gov/show/NCT02260193
2326123261Study of A-101 for the Treatment of Seborrheic KeratosisCompletedNo Results AvailableSeborrheic KeratosisDrug: A-101https://ClinicalTrials.gov/show/NCT02260180
2326223262Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) ProtocolRecruitingNo Results AvailableAlzheimer's Disease|DementiaOther: A mix of natural treatments and medicationshttps://ClinicalTrials.gov/show/NCT02260167
2326323263Effectiveness of Duspatalin® in Patients With Post-cholecystectomy Gastrointestinal SpasmRecruitingNo Results AvailablePost-cholecystectomy Gastrointestinal SpasmsDrug: Mebeverinehttps://ClinicalTrials.gov/show/NCT02260154
2326423264Treating Alzheimer's and Dementia With D-riboseRecruitingNo Results AvailableAlzheimers|DementiaDietary Supplement: d-ribosehttps://ClinicalTrials.gov/show/NCT02260141
2326523265Effect of Chewing Gum on Postoperative Bowel Function Following Upper GI Tract Cancer SurgeryNot yet recruitingNo Results AvailableCancer Esophagus|Pancreatic CancerOther: Chewing gumhttps://ClinicalTrials.gov/show/NCT02260128
2326623266A Randomized Multi-centre Study to Assess the Safety and Manageability of a Laparoscopic Adhesion Barrier in Women Undergoing Gynecologic Laparoscopic Surgery Followed by Second Look LaparoscopyActive, not recruitingNo Results AvailableTissue AdhesionsDevice: LABSâ„¢|Procedure: Surgical Controlhttps://ClinicalTrials.gov/show/NCT02260115
2326723267Temocillin Pharmacokinetics in PaediatricsNot yet recruitingNo Results AvailableInfection|Liver Dysfunction|Urinary Tract InfectionDrug: Temocillinhttps://ClinicalTrials.gov/show/NCT02260102
2326823268Telmisartan in Mild to Moderate Hypertensive PatientsCompletedNo Results AvailableHypertensionDrug: Low dose of telmisartan|Drug: High dose of telmisartan|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02260089
2326923269Safety of Total Daily Doses of Polyethylene Glycol (PEG) 400 Administered Orally to Healthy Male Human SubjectsCompletedNo Results AvailableHealthyDrug: PEG 400|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02260076
2327023270Relative Bioavailability of Epinastine Syrup Compared to Tablets in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Epinastine syrup|Drug: Epinastine tabletshttps://ClinicalTrials.gov/show/NCT02260063
2327123271Bioequivalence of the New Formulation of WAL 801 CL Dry Syrup Compared to the Conventional Formulation of WAL 801 CL Dry Syrup in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: WAL 801 CL dry syrup new formulation|Drug: WAL 801 CL dry syrup conventional formulationhttps://ClinicalTrials.gov/show/NCT02260050
2327223272Dose Tolerance Study in Healthy Male Volunteers After Intranasal Application of Epinastine NasalCompletedNo Results AvailableHealthyDrug: Epinastine nasal|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02260037
2327323273In Vitro/in Vivo Correlation (IVIVC) for Oral Slow Release (SR) Tablets Pramipexole in Healthy Male VolunteersCompletedNo Results AvailableHealthyOther: High fat, high caloric meal|Drug: Pramipexole IR tablets|Drug: Pramipexole SR C|Drug: Pramipexole SR C2|Drug: Pramipexole SR C2A|Drug: Pramipexole SR C2Bhttps://ClinicalTrials.gov/show/NCT02260024
2327423274Study of the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to the Market Standard, Atrovent® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Ipratropium bromide HFA-134a inhalation aerosol|Drug: Atrovent® CFC inhalation aerosol|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02260011
2327523275Pharmacokinetics of Two Different Persantin® Sugar Coated Tablets in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: Persantin® new formulation|Drug: Persantin® commercial formulationhttps://ClinicalTrials.gov/show/NCT02259998
2327623276Effects of Food on the Bioavailability and Pharmacokinetic Profile of Itasetron After a Single Oral Dose in Healthy Male SubjectsCompletedNo Results AvailableHealthyDrug: Itasetron tablet|Drug: Itasetron infusion|Other: high fat breakfasthttps://ClinicalTrials.gov/show/NCT02259985
2327723277Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 113823 Powder in Bottle (PiB) and Tablet in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BI 113823 solution|Drug: BI 113823 tablet|Drug: Placebo|Other: High fat, high calorie breakfasthttps://ClinicalTrials.gov/show/NCT02259972
2327823278Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BI 1744 CL in Fixed Dose Combination With Tiotropium Bromide in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: Single rising doses of BI 1744 CL, solution for oral inhalation|Drug: Tiotropium, fixed dose, solution for oral inhalation|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02259959
2327923279Study to Investigate Safety and Tolerability of BI 1744 CL in Free Dose Combination With Tiotropium Bromide Both Administered by Respimat® in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BI 1744 CL|Drug: Placebo|Drug: Tiotropium bromidehttps://ClinicalTrials.gov/show/NCT02259946
2328023280Safety, Tolerability and Pharmacokinetics of KUC 7483 CL Tablets in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: KUC 7483 CL|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02259933

* Görseller ve İçerik tekif hakkına sahip olabilir